The USRDS
Open Access
- 1 May 2013
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 8 (5), 845-851
- https://doi.org/10.2215/cjn.06840712
Abstract
This article summarizes the administrative structure underlying the Unites States Renal Data System (USRDS); summarizes incidence, prevalence, patient characteristics, and treatment modalities; and describes data regarding clinical indicators and preventive care, hospitalization, survival, and costs. The USRDS recently instituted a comprehensive assessment system to characterize the transition to the new Centers for Medicare & Medicaid Services Prospective Payment System, which bundles into a single payment several integral components of dialysis care. This challenging initiative will be an important component of future USRDS Annual Data Reports. The main strengths of the USRDS are its size and representativeness, nearly complete inclusion of the US end-stage renal disease population, and linkage to Medicare claims. Limitations include lack of continuous validation of its methods, lack of complete comorbidity and laboratory data at registration, an initial survival bias, and lack of accuracy of cause-of-death reporting.This publication has 9 references indexed in Scilit:
- Long Interdialytic Interval and Mortality among Patients Receiving HemodialysisThe New England Journal of Medicine, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Rehospitalizations among Patients in the Medicare Fee-for-Service ProgramThe New England Journal of Medicine, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patientsKidney International, 2007
- Atherosclerotic Renovascular Disease in Older US Patients Starting Dialysis, 1996 to 2001Circulation, 2007
- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing HemodialysisThe New England Journal of Medicine, 2005
- Comparison of causes of death using HEMO study and HCFA end-stage renal disease death notification classification systemsAmerican Journal of Kidney Diseases, 2002